Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer

PURPOSE: To prospectively compare HRQoL effects of two modern adjuvant chemotherapy breast cancer treatment regimens at six time-points up to 16 months after random assignment. METHODS: The open-label, randomized, Phase 3 “Panther trial” was conducted between February 2007 and September 2011. 760 wo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Breast Cancer Res Treat
Autori principali: Brandberg, Yvonne, Johansson, Hemming, Hellström, Mats, Gnant, Michael, Möbus, Volker, Greil, Richard, Foukakis, Theodoros, Bergh, Jonas
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer US 2020
Soggetti:
Clinical Trial
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7182635/
https://ncbi.nlm.nih.gov/pubmed/32232698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05602-9
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi